Low frequency of E-cadherinalterations in familial breast cancer
Sima Salahshor(Mount Sinai Hospital), Annika Lindblom(Karolinska University Hospital), Huagang Huo(Karolinska Institutet), Vessela N. Kristensen(Oslo University Hospital), Haixin Lei(Dalian Medical University), Anne‐Lise Børresen‐Dale(Oslo University Hospital), Åke Borg(Lund University), Niklas Loman(Lund University), Sara Margolin(University of Copenhagen), Igor Vořechovský(The Royal Free Hospital)
Cited by 48
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
|The Lancet|2010|2.3k
The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes
|Nature Communications|2016|1.8k